April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Genprex (GNPX) stock forecast for 2025
Updated: April 23, 2024 (06:51)
Sector: HealthcareThe share price of Genprex, Inc. (GNPX) now
50/200 Day Moving Average: $3.645 / $12.85
This figure corresponds to the Average Price over the previous 50/200 days. For Genprex stocks, the 50-day moving average is the resistance level today.
For Genprex stocks, the 200-day moving average is the resistance level today.
Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2025. How much will one Genprex share be worth in 2025? Is it worth taking profit / loss on GNPX stock now or waiting? What are analysts' forecasts for Genprex stock?
We forecast Genprex stock performance using neural networks based on historical data on GNPX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Genprex, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Genprex analysts is $165. Today 200 Day Moving Average is the resistance level (12.85 $). 50 Day Moving Average is the resistance level (3.645 $).
Historical and forecast chart of Genprex, Inc. stock
The chart below shows the historical price of Genprex stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GNPX stock price can be found in the table below.
Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).
Genprex (GNPX) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.41 | 4.96 | 5.63 | 11.85 % |
| Feb | 6.22 | 5.61 | 6.98 | 19.66 % |
| Mar | 6.06 | 5.38 | 6.32 | 14.88 % |
| Apr | 5.20 | 4.60 | 5.85 | 21.37 % |
| May | 5.11 | 4.84 | 5.62 | 13.83 % |
| Jun | 5.81 | 5.17 | 6.24 | 17.26 % |
| Jul | 5.40 | 4.86 | 5.80 | 16.10 % |
| Aug | 5.30 | 4.85 | 5.78 | 15.98 % |
| Sep | 4.92 | 4.47 | 5.39 | 17.23 % |
| Oct | 5.65 | 5.25 | 6.10 | 13.93 % |
| Nov | 5.48 | 5.22 | 5.87 | 11.04 % |
| Dec | 5.51 | 5.09 | 5.97 | 14.77 % |
Genprex information and performance
100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US
Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.
EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Genprex price target for 2025 by month
Target values for the price of one Genprex share for Jan 2025.
In Jan, the Positive dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 11.846% volatility is expected.
Pessimistic target level: 4.96
Optimistic target level: 5.63
Target values for the price of one Genprex share for Feb 2025.
In Feb, the Positive dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 19.658% volatility is expected.
Pessimistic target level: 5.61
Optimistic target level: 6.98
Target values for the price of one Genprex share for Mar 2025.
In Mar, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 14.877% volatility is expected.
Pessimistic target level: 5.38
Optimistic target level: 6.32
Target values for the price of one Genprex share for Apr 2025.
In Apr, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 21.367% volatility is expected.
Pessimistic target level: 4.60
Optimistic target level: 5.85
Target values for the price of one Genprex share for May 2025.
In May, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 13.828% volatility is expected.
Pessimistic target level: 4.84
Optimistic target level: 5.62
Target values for the price of one Genprex share for Jun 2025.
In Jun, the Positive dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 17.262% volatility is expected.
Pessimistic target level: 5.17
Optimistic target level: 6.24
Target values for the price of one Genprex share for Jul 2025.
In Jul, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 16.095% volatility is expected.
Pessimistic target level: 4.86
Optimistic target level: 5.80
Target values for the price of one Genprex share for Aug 2025.
In Aug, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 15.982% volatility is expected.
Pessimistic target level: 4.85
Optimistic target level: 5.78
Target values for the price of one Genprex share for Sep 2025.
In Sep, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 17.226% volatility is expected.
Pessimistic target level: 4.47
Optimistic target level: 5.39
Target values for the price of one Genprex share for Oct 2025.
In Oct, the Positive dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 13.926% volatility is expected.
Pessimistic target level: 5.25
Optimistic target level: 6.10
Target values for the price of one Genprex share for Nov 2025.
In Nov, the Negative dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 11.045% volatility is expected.
Pessimistic target level: 5.22
Optimistic target level: 5.87
Target values for the price of one Genprex share for Dec 2025.
In Dec, the Positive dynamics for Genprex, Inc. shares will prevail with possible monthly volatility of 14.771% volatility is expected.
Pessimistic target level: 5.09
Optimistic target level: 5.97
